Page last updated: 2024-08-23

bisantrene and Melanoma

bisantrene has been researched along with Melanoma in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (66.67)	18.7374
1990's	2 (22.22)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Marco, C; Folini, M; Palumbo, M; Pivetta, C; Sissi, C; Zaffaroni, N; Zagotto, G	1
Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE	1
Angier, RB; Citarella, RV; Durr, FE; Forbes, M; Murdock, KC; Wallace, RE	1
Annable, T; Arceci, RJ; Collins, KI; Durr, FE; Greenberger, LM; Ho, JP; Ritke, MK; Slovak, ML; Yalowich, JC; Zhang, XP	1
Blough, RR; Johnson, CM; Kilton, LJ; Muntean, B; Stiff, PJ; Sweet, D	1
Alberts, DS; Cowan, JD; Epstein, RB; Fletcher, WS; Green, SJ; Guy, JT; Mason-Liddil, N; Neilan, B	1
Alberts, DS; Mackel, C; Meyskens, FL	1
Bishop, J; Coates, AS; Mann, GJ; Raghavan, D	1
Citarella, RV; Durr, FE; McWilliams, W; Nicolau, G; Wu, WH	1

Trials

1 trial(s) available for bisantrene and Melanoma

Article	Year
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay. Cancer research, 1982, Volume: 42, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms	1982

Article

Year

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.

Cancer research, 1982, Volume: 42, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms

1982

Other Studies

8 other study(ies) available for bisantrene and Melanoma

Article	Year
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer. Biochemical pharmacology, 2010, Jun-15, Volume: 79, Issue:12 Topics: Anthracenes; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; G-Quadruplexes; Humans; Inhibitory Concentration 50; Isomerism; Melanoma; Molecular Structure; Nucleic Acid Denaturation; Osteosarcoma; Structure-Activity Relationship; Taq Polymerase; Telomerase; Telomere	2010
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Cancer research, 1982, Volume: 42, Issue:2 Topics: Animals; Anthracenes; Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fluorouracil; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma	1982
P-glycoprotein mediates profound resistance to bisantrene. Oncology research, 1994, Volume: 6, Issue:7 Topics: Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chromosome Banding; Chromosomes, Human; Clone Cells; Colonic Neoplasms; DNA Primers; Drug Resistance, Multiple; Humans; In Situ Hybridization, Fluorescence; KB Cells; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Transfection; Tumor Cells, Cultured	1994
Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study. Medical and pediatric oncology, 1991, Volume: 19, Issue:2 Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Illinois; Infusions, Intravenous; Leukopenia; Male; Melanoma; Middle Aged; Phlebitis; Survival Rate	1991
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group Study. Investigational new drugs, 1987, Volume: 5, Issue:3 Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged	1987
Phase II trial of bisantrene in patients with metastatic melanoma. Cancer treatment reports, 1986, Volume: 70, Issue:8 Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis	1986
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:1 Topics: Aminoacridines; Amsacrine; Anthracenes; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Mitoxantrone; Phlebitis; Skin Neoplasms	1986
Tissue deposition of bisantrene in B16 melanoma tumor-bearing mice. Cancer investigation, 1986, Volume: 4, Issue:1 Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Carbon Radioisotopes; Cell Line; Male; Melanoma; Mice; Mice, Inbred Strains; Tissue Distribution	1986